UK cancer charity in major alliance with AstraZeneca

Sunday 7 February 2010

Cancer Research Technology (CRT) has entered into a three-year drug discovery and development alliance with AstraZeneca Plc that is expected to lead to the identification of new small molecule drugs targeting changes in a cell’s metabolism.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom